Methods and compositions comprising at least one α3 4 nAChR antagonist or pharmaceutically acceptable salt thereof
The present invention is directed to methods and formulations for treating, modifying, and/or managing gastrointestinal secretion, and intestinal conditions that cause the same. Methods of using at least one α3 4 nAChR antagonist and formulations comprising at least one α3 4 nAChR antagonist, or pha...
Saved in:
Main Author | |
---|---|
Format | Patent |
Language | English |
Published |
26.05.2015
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention is directed to methods and formulations for treating, modifying, and/or managing gastrointestinal secretion, and intestinal conditions that cause the same. Methods of using at least one α3 4 nAChR antagonist and formulations comprising at least one α3 4 nAChR antagonist, or pharmaceutically acceptable salt thereof, are included. |
---|---|
Bibliography: | Application Number: US201213553453 |